Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications

BACKGROUND: Fingolimod, an immunomodulatory agent, is used for the treatment of relapsing–remitting multiple sclerosis (RRMS). Fingolimod-associated macular edema (FAME) is a known complication with an incidence of 0.4%. The current recommendation for treatment of FAME is cessation of fingolimod. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Husmann, Rachel, Davies, John B., Ghannam, Malik, Berry, Brent, Kelkar, Praful
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066779/
https://www.ncbi.nlm.nih.gov/pubmed/32190009
http://dx.doi.org/10.1186/s12948-020-00119-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066779/
https://www.ncbi.nlm.nih.gov/pubmed/32190009
http://dx.doi.org/10.1186/s12948-020-00119-4

Ejemplares similares